project id: TCGA-MESO; case submitter id: TCGA-MQ-A4LJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.17; rna integrity number: 8.2; age at index: 53; days to birth: -19437; days to death: 709; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1946; year of death: 2000; age at diagnosis: 19437; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 1999; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 130.0; sample id: 96324ec4-ad1b-41f6-bab0-322724aa9b15; sample submitter id: TCGA-MQ-A4LJ-01A; portion id: 6eec56e5-b735-407b-a27a-943af56c5a70; portion submitter id: TCGA-MQ-A4LJ-01A-11; slide id: 80893aaf-6dd5-4909-8f56-7225864283f2; slide submitter id: TCGA-MQ-A4LJ-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; section location: TOP;